Peptides DB
Research-centric peptide and protocol reference hub

CJC IPA Protocol (CJC-1295/Ipamorelin) record · updated 20h ago

Muscle & body compMetabolic & appetiteGrade D · emergingResearch use only
Evidence for its componentsCompare
What is CJC IPA Protocol (CJC-1295/Ipamorelin) used for?

CJC-1295/Ipamorelin is a research peptide stack pairing a GHRH analog with a selective ghrelin receptor agonist to amplify endogenous growth hormone release.

How it works: GHRH (1–29) analog, modified

Primarily researched for · Muscle & body compRoute · Subcutaneous injection

Development stage

where CJC IPA Protocol (CJC-1295/Ipamorelin) sits between preclinical work and regulatory approval
  1. 1Current
    Preclinical
    Animal / in-vitro work
  2. 2Not reached
    Phase 1
    Safety in humans
  3. 3Not reached
    Phase 2
    Efficacy signal
  4. 4Not reached
    Phase 3
    Confirmatory trials
  5. 5Not reached
    Approved
    Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus. It describes the research record, not a recommendation.

Identity
NameCJC IPA Protocol (CJC-1295/Ipamorelin)
Chain length—
Molecular weight—
Formula—
Structure type—
ClassGH
Research levelWell Studied
Discovered byCurated master list · 2026
Pharmacology
MechanismGHRH (1–29) analog, modified
RouteSubcutaneous injection
Half-life~30 min
Time to peak—
Duration—
Extraction confidence0.60
Effect profile · 0–5
These seven scores are generated by the Librarian — an autonomous agent running GPT-4o over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. How this works →
Research stats
Total studies0
Human / animal / cellular0 / 0 / 0
Highest trial phase—
Years covered2026–2026
Latest study—
Publication history
No publication years on file
——
Research funding
—no NIH grants found
Safety signals
FAERS reportsnone recorded
Serious AEs in animal work—
Community reports—
Positive —Neutral —Negative —
Records

Study register

no studies of its own · newest 12 of 17 from its componentsOpen in the library →
No direct evidence

No study in this library has tested this combination directly. The papers below examined its components individually — each row is labelled with the single compound that study looked at.

Evidence for one component is not evidence for the combination. Nothing below measured what happens when these compounds are used together.

StudyTypeYearSummary depth
Variations in the association between standalone and coexisting forms of undernutrition and common infectious morbidities among children in sub-Saharan Africa.
Finding30.20% prevalence of common infectious morbidity among children under five in SSA (95% CI: 27.34, 33.06)
Human2026Full text read0.80
Compliance with preoperative antibiotic prophylaxis in cesarean delivery and its impact on surgical site infections: A national retrospective study of Jordan.
Finding19.4% of patients received PAP as recommended.
Human2026Full text read0.90
Dengzhanxixin injection for acute ischemic stroke after reperfusion therapy: A double-blind, placebo-controlled, multi-center clinical trial.
Finding78.21% with mRS 0-1 at 90 days in high-dose group
Human2026Full text read0.90
Robotic-assisted intracorporeal radical cystectomy with modified ileal conduit reduces ureteroileal anastomotic stenosis risk: a comparative study with laparoscopic surgery.
Finding0% stenosis in robotic group vs 15.22% in laparoscopic, p=0.043
Human2026Full text read0.80
Recommendations for quality care indicators in severe asthma multidisciplinary units in Portugal (PRECISION project): A nationwide consensus.
FindingConsensus achieved on 28/54 statements (51.9%).
review2026Full text read0.80
Development and diagnostic performance of a modified O-RADS model incorporating septa number and blood flow for adnexal lesions.
FindingMalignancy rate of 45.3% in the 4b subclass (86 masses), n=86.
Human2026Full text read0.80
Metformin added to lifestyle intervention for physical function in older adults with obesity (DEMFOS trial): a randomised controlled trial.
FindingAt 6 months, physical performance test improvement was greater in the intensive lifestyle plus metformin group than in the healthy lifestyle plus metformin group (mean difference 2·5 points, 95% CI 1·2-3·8; p=0·0002)
Human2026Full text read0.80
Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications.
TakeawayInjectable peptides like CJC-1295 are still largely experimental, and clinicians should be cautious about their use due to uncertain efficacy and safety risks.
review2026Full text read0.80
Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications.
TakeawayInjectable peptides for sports medicine are largely experimental and clinicians should be cautious about their efficacy and safety, particularly regarding products like CJC-1295.
review2026Full text read0.70
Semantic Scholar search for Ipamorelin
TakeawayNot reported in abstract.
—2010Title only0.00
Semantic Scholar search for CJC-1295
TakeawayNot reported in abstract.
—2010Title only0.00
Attenuation of Visceral and Somatic Nociception by Ghrelin Mimetics.
FindingNot reported in abstract.
Animal2020Partial text0.50

What people are saying

anecdotal · not evidence

Unverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching CJC IPA Protocol (CJC-1295/Ipamorelin) will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.

Community collection has not run yet, so this is an empty shelf rather than a quiet one — nothing has been read, and no conclusion about how much CJC IPA Protocol (CJC-1295/Ipamorelin) is discussed should be drawn from it.